Improvement of HbA1c in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis Treated with bDMARDs
Alfredomaria Lurati,1 Antonella Laria,1 Daniela Mazzocchi,1 Katia Angela Re,1 Maria Grazia Marrazza,1 Paola Maria Faggioli,2 Antonino Mazzone2 1Rheumatology Unit, Fornaroli Hospital Magenta Italy, Milan, Italy; 2Internal Medicine Unit, Legnano Hospital, Milan, ItalyCorrespondence: Alfredomaria Lurat...
Guardado en:
Autores principales: | Lurati A, Laria A, Mazzocchi D, Re KA, Marrazza MG, Faggioli PM, Mazzone A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/25b05d17f5b84971bc43f6a35f853242 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
por: Findeisen KE, et al.
Publicado: (2021) -
Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
por: Mysler E, et al.
Publicado: (2021) -
The onset of rheumatoid arthritis following trauma
por: Brawer AE, et al.
Publicado: (2016) -
Risk Factors Associated with Methotrexate Intolerance in Rheumatoid Arthritis Patients
por: Almalag H, et al.
Publicado: (2020) -
Management of rheumatoid arthritis during pregnancy: challenges and solutions
por: Krause ML, et al.
Publicado: (2016)